PolarityTE, Inc. (PTE) News
Filter PTE News Items
PTE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest PTE News From Around the Web
Below are the latest news stories about POLARITYTE INC that investors may wish to consider to help them evaluate PTE as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start breaking down the biggest pre-market movers for Thursday as we get ready for another busy day of trading! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to start off the day right with a dive into the biggest pre-market stock movers worth watching on Tuesday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're starting the day off right with a breakdown of the biggest pre-market stock movers worth reading about on Wednesday! |
PolarityTE, Inc. (PTE) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowPolarityTE, Inc. (PTE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. |
PolarityTE Full Year 2022 Earnings: EPS Misses ExpectationsPolarityTE ( NASDAQ:PTE ) Full Year 2022 Results Key Financial Results Net loss: US$7.83m (loss narrowed by 74% from FY... |
When Can We Expect A Profit From PolarityTE, Inc. (NASDAQ:PTE)?With the business potentially at an important milestone, we thought we'd take a closer look at PolarityTE, Inc.'s... |
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the CompanyPolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today announced that it signed a non-binding letter of intent (the "LOI") with Michael Brauser ("Brauser") for him to make an offer to acquire 100% of the outstanding equity interests of the Company at a proposed offering price of $1.03 per common share, which would be paid entirely in cash. As of December 23, 2022, there were 7,256,786 shares of the Company's common |
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business UpdatePolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the quarterly period ended September 30, 2022. |
PolarityTE Shares Jump After Non-Binding Buyout Offer Of $1.25/SharePolarityTE Inc (NASDAQ: PTE) shares are surging after it received an unsolicited, non-binding offer (followed by an amended offer) from Michael Brauser to acquire all of the outstanding common stock of the company not owned by him for $1.25 per share in cash. The company's board and a special committee will carefully review the terms and conditions of the offer to determine the course of action that it believes is in the best interest of the company and all Company security holders. If the Board |
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the CompanyPolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash. The offer is subject to various contingencies, including, among others, (1) settlement with warrant holders and satisf |